Inpatient outcomes for lung cancer patients presenting with superior vena cava thrombosis
CONCLUSION: Race, insurance type, and comorbidities impacted the likelihood of developing SVC thrombosis in patients with lung cancer. SVC thrombosis is a poor prognostic factor for patients with lung cancer. Further studies to evaluate these disparities are warranted.PMID:38628350 | PMC:PMC11018079 | DOI:10.1080/08998280.2024.2317698 (Source: Baylor University Medical Center Proceedings)
Source: Baylor University Medical Center Proceedings - April 17, 2024 Category: Universities & Medical Training Authors: Jay Vakil Ekrem Turk Maria Cristina Cuartas-Mesa Vaishali Deenadayalan Kunnal Batra Source Type: research
Inpatient outcomes for lung cancer patients presenting with superior vena cava thrombosis
CONCLUSION: Race, insurance type, and comorbidities impacted the likelihood of developing SVC thrombosis in patients with lung cancer. SVC thrombosis is a poor prognostic factor for patients with lung cancer. Further studies to evaluate these disparities are warranted.PMID:38628350 | PMC:PMC11018079 | DOI:10.1080/08998280.2024.2317698 (Source: Baylor University Medical Center Proceedings)
Source: Baylor University Medical Center Proceedings - April 17, 2024 Category: Universities & Medical Training Authors: Jay Vakil Ekrem Turk Maria Cristina Cuartas-Mesa Vaishali Deenadayalan Kunnal Batra Source Type: research
Inpatient outcomes for lung cancer patients presenting with superior vena cava thrombosis
CONCLUSION: Race, insurance type, and comorbidities impacted the likelihood of developing SVC thrombosis in patients with lung cancer. SVC thrombosis is a poor prognostic factor for patients with lung cancer. Further studies to evaluate these disparities are warranted.PMID:38628350 | PMC:PMC11018079 | DOI:10.1080/08998280.2024.2317698 (Source: Baylor University Medical Center Proceedings)
Source: Baylor University Medical Center Proceedings - April 17, 2024 Category: Universities & Medical Training Authors: Jay Vakil Ekrem Turk Maria Cristina Cuartas-Mesa Vaishali Deenadayalan Kunnal Batra Source Type: research
Inpatient outcomes for lung cancer patients presenting with superior vena cava thrombosis
CONCLUSION: Race, insurance type, and comorbidities impacted the likelihood of developing SVC thrombosis in patients with lung cancer. SVC thrombosis is a poor prognostic factor for patients with lung cancer. Further studies to evaluate these disparities are warranted.PMID:38628350 | PMC:PMC11018079 | DOI:10.1080/08998280.2024.2317698 (Source: Baylor University Medical Center Proceedings)
Source: Baylor University Medical Center Proceedings - April 17, 2024 Category: Universities & Medical Training Authors: Jay Vakil Ekrem Turk Maria Cristina Cuartas-Mesa Vaishali Deenadayalan Kunnal Batra Source Type: research
Inpatient outcomes for lung cancer patients presenting with superior vena cava thrombosis
CONCLUSION: Race, insurance type, and comorbidities impacted the likelihood of developing SVC thrombosis in patients with lung cancer. SVC thrombosis is a poor prognostic factor for patients with lung cancer. Further studies to evaluate these disparities are warranted.PMID:38628350 | PMC:PMC11018079 | DOI:10.1080/08998280.2024.2317698 (Source: Baylor University Medical Center Proceedings)
Source: Baylor University Medical Center Proceedings - April 17, 2024 Category: Universities & Medical Training Authors: Jay Vakil Ekrem Turk Maria Cristina Cuartas-Mesa Vaishali Deenadayalan Kunnal Batra Source Type: research
Inpatient outcomes for lung cancer patients presenting with superior vena cava thrombosis
CONCLUSION: Race, insurance type, and comorbidities impacted the likelihood of developing SVC thrombosis in patients with lung cancer. SVC thrombosis is a poor prognostic factor for patients with lung cancer. Further studies to evaluate these disparities are warranted.PMID:38628350 | PMC:PMC11018079 | DOI:10.1080/08998280.2024.2317698 (Source: Baylor University Medical Center Proceedings)
Source: Baylor University Medical Center Proceedings - April 17, 2024 Category: Universities & Medical Training Authors: Jay Vakil Ekrem Turk Maria Cristina Cuartas-Mesa Vaishali Deenadayalan Kunnal Batra Source Type: research
Inpatient outcomes for lung cancer patients presenting with superior vena cava thrombosis
CONCLUSION: Race, insurance type, and comorbidities impacted the likelihood of developing SVC thrombosis in patients with lung cancer. SVC thrombosis is a poor prognostic factor for patients with lung cancer. Further studies to evaluate these disparities are warranted.PMID:38628350 | PMC:PMC11018079 | DOI:10.1080/08998280.2024.2317698 (Source: Baylor University Medical Center Proceedings)
Source: Baylor University Medical Center Proceedings - April 17, 2024 Category: Universities & Medical Training Authors: Jay Vakil Ekrem Turk Maria Cristina Cuartas-Mesa Vaishali Deenadayalan Kunnal Batra Source Type: research
Inpatient outcomes for lung cancer patients presenting with superior vena cava thrombosis
CONCLUSION: Race, insurance type, and comorbidities impacted the likelihood of developing SVC thrombosis in patients with lung cancer. SVC thrombosis is a poor prognostic factor for patients with lung cancer. Further studies to evaluate these disparities are warranted.PMID:38628350 | PMC:PMC11018079 | DOI:10.1080/08998280.2024.2317698 (Source: Baylor University Medical Center Proceedings)
Source: Baylor University Medical Center Proceedings - April 17, 2024 Category: Universities & Medical Training Authors: Jay Vakil Ekrem Turk Maria Cristina Cuartas-Mesa Vaishali Deenadayalan Kunnal Batra Source Type: research
Inpatient outcomes for lung cancer patients presenting with superior vena cava thrombosis
CONCLUSION: Race, insurance type, and comorbidities impacted the likelihood of developing SVC thrombosis in patients with lung cancer. SVC thrombosis is a poor prognostic factor for patients with lung cancer. Further studies to evaluate these disparities are warranted.PMID:38628350 | PMC:PMC11018079 | DOI:10.1080/08998280.2024.2317698 (Source: Baylor University Medical Center Proceedings)
Source: Baylor University Medical Center Proceedings - April 17, 2024 Category: Universities & Medical Training Authors: Jay Vakil Ekrem Turk Maria Cristina Cuartas-Mesa Vaishali Deenadayalan Kunnal Batra Source Type: research
Inpatient outcomes for lung cancer patients presenting with superior vena cava thrombosis
CONCLUSION: Race, insurance type, and comorbidities impacted the likelihood of developing SVC thrombosis in patients with lung cancer. SVC thrombosis is a poor prognostic factor for patients with lung cancer. Further studies to evaluate these disparities are warranted.PMID:38628350 | PMC:PMC11018079 | DOI:10.1080/08998280.2024.2317698 (Source: Baylor University Medical Center Proceedings)
Source: Baylor University Medical Center Proceedings - April 17, 2024 Category: Universities & Medical Training Authors: Jay Vakil Ekrem Turk Maria Cristina Cuartas-Mesa Vaishali Deenadayalan Kunnal Batra Source Type: research
Inpatient outcomes for lung cancer patients presenting with superior vena cava thrombosis
CONCLUSION: Race, insurance type, and comorbidities impacted the likelihood of developing SVC thrombosis in patients with lung cancer. SVC thrombosis is a poor prognostic factor for patients with lung cancer. Further studies to evaluate these disparities are warranted.PMID:38628350 | PMC:PMC11018079 | DOI:10.1080/08998280.2024.2317698 (Source: Baylor University Medical Center Proceedings)
Source: Baylor University Medical Center Proceedings - April 17, 2024 Category: Universities & Medical Training Authors: Jay Vakil Ekrem Turk Maria Cristina Cuartas-Mesa Vaishali Deenadayalan Kunnal Batra Source Type: research
Inpatient outcomes for lung cancer patients presenting with superior vena cava thrombosis
CONCLUSION: Race, insurance type, and comorbidities impacted the likelihood of developing SVC thrombosis in patients with lung cancer. SVC thrombosis is a poor prognostic factor for patients with lung cancer. Further studies to evaluate these disparities are warranted.PMID:38628350 | PMC:PMC11018079 | DOI:10.1080/08998280.2024.2317698 (Source: Baylor University Medical Center Proceedings)
Source: Baylor University Medical Center Proceedings - April 17, 2024 Category: Universities & Medical Training Authors: Jay Vakil Ekrem Turk Maria Cristina Cuartas-Mesa Vaishali Deenadayalan Kunnal Batra Source Type: research
Inpatient outcomes for lung cancer patients presenting with superior vena cava thrombosis
CONCLUSION: Race, insurance type, and comorbidities impacted the likelihood of developing SVC thrombosis in patients with lung cancer. SVC thrombosis is a poor prognostic factor for patients with lung cancer. Further studies to evaluate these disparities are warranted.PMID:38628350 | PMC:PMC11018079 | DOI:10.1080/08998280.2024.2317698 (Source: Baylor University Medical Center Proceedings)
Source: Baylor University Medical Center Proceedings - April 17, 2024 Category: Universities & Medical Training Authors: Jay Vakil Ekrem Turk Maria Cristina Cuartas-Mesa Vaishali Deenadayalan Kunnal Batra Source Type: research
Inpatient outcomes for lung cancer patients presenting with superior vena cava thrombosis
CONCLUSION: Race, insurance type, and comorbidities impacted the likelihood of developing SVC thrombosis in patients with lung cancer. SVC thrombosis is a poor prognostic factor for patients with lung cancer. Further studies to evaluate these disparities are warranted.PMID:38628350 | PMC:PMC11018079 | DOI:10.1080/08998280.2024.2317698 (Source: Baylor University Medical Center Proceedings)
Source: Baylor University Medical Center Proceedings - April 17, 2024 Category: Universities & Medical Training Authors: Jay Vakil Ekrem Turk Maria Cristina Cuartas-Mesa Vaishali Deenadayalan Kunnal Batra Source Type: research
Inpatient outcomes for lung cancer patients presenting with superior vena cava thrombosis
CONCLUSION: Race, insurance type, and comorbidities impacted the likelihood of developing SVC thrombosis in patients with lung cancer. SVC thrombosis is a poor prognostic factor for patients with lung cancer. Further studies to evaluate these disparities are warranted.PMID:38628350 | PMC:PMC11018079 | DOI:10.1080/08998280.2024.2317698 (Source: Baylor University Medical Center Proceedings)
Source: Baylor University Medical Center Proceedings - April 17, 2024 Category: Universities & Medical Training Authors: Jay Vakil Ekrem Turk Maria Cristina Cuartas-Mesa Vaishali Deenadayalan Kunnal Batra Source Type: research
